IFIT1 and IFIT3 genes are classified as IRDS subset genes and are considered as predictive biomarkers for chemotherapy and radiation therapy in many primary human cancers, such as breast cancer, head and neck cancer, prostate cancer, lung cancer, and glioma (Weichselbaum et al., 2008). The gene discussed is IFIT3; the disease is breast cancer.